The Ongoing Federal Rescheduling and Operational Hurdles in Cannabis

Blunt Business welcomes Joe Bayern, the CEO of MM Brands to discuss how the cannabis industry is approaching a potential turning point as DOJ and DEA hearings conclude this July, with anticipation high for a move to Schedule 3 classification. This reclassification could eliminate 280E tax constraints, driving better profitability, while FDA validation of therapeutic benefits promises to reduce stigma and build consumer trust. Despite this momentum, the sector faces significant headwinds, specifically a critical shortage of experienced middle management and the ongoing difficulty of maintaining quality control and compliance amidst fragmented, state-specific regulations.Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy